• In late April 2026, Centene Corporation reported first-quarter revenue of US$49.94 billion and net income of US$1.54 billion, with both basic and diluted EPS from continuing operations rising year on year.
• Alongside these results, Centene raised its 2026 earnings guidance, highlighting stronger-than-expected margins in its Medicaid and Medicare businesses while working to reprice its challenged Marketplace segment.
• We’ll now examine how Centene’s upgraded 2026 earnings outlook, driven by Medicaid and Medicare margin improvements, affects its existing investment narrative.

Capitalize on the AI infrastructure supercycle with our selection of the 38 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

Centene Investment Narrative Recap

To own Centene, you have to believe it can steadily improve margins in government-backed programs like Medicaid and Medicare while fixing its troubled Marketplace book. The latest earnings beat and guidance raise support the near term margin recovery catalyst, but they do not remove the key risk around policy and rate adequacy, especially if reimbursement fails to keep pace with medical cost trends.

The most relevant recent announcement is Centene’s upgraded 2026 guidance to GAAP diluted EPS of more than US$2.37 on revenue of US$187.5 billion to US$191.5 billion. This ties directly to the stronger first quarter performance in Medicaid and Medicare, reinforcing the margin recovery story that many investors are watching, even as the Marketplace repricing and regulatory backdrop remain critical swing factors.

Yet investors should be aware that growing regulatory pressure on Medicaid and Marketplace reimbursement could still...

Centene's narrative projects $199.0 billion revenue and $2.8 billion earnings by 2029. This requires 3.5% yearly revenue growth and about a $9.2 billion earnings increase from -$6.4 billion today.

Uncover how Centene's forecasts yield a $43.47 fair value, a 19% downside to its current price.

Exploring Other Perspectives

Some of the lowest ranked analysts were far more cautious, assuming revenue of about US$181.3 billion and earnings of only US$392.3 million by 2028, so if you worry about tighter reimbursement and tougher rate negotiations you may find their more pessimistic margin view worth exploring alongside this strong quarter.

Explore 16 other fair value estimates on Centene - why the stock might be worth over 4x more than the current price!

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Centene research is our analysis highlighting 3 key rewards that could impact your investment decision.
• Our free Centene research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Centene's overall financial health at a glance.

Interested In Other Possibilities?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

• Rare earth metals are the new gold rush. Find out which 32 stocks are leading the charge.
• Find 53 companies with promising cash flow potential yet trading below their fair value.
• The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 16 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.